RICHARD RUSSELL: Open Payments
NPI 1063584175 · MADISON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,426 in 71 payments from 16 companies in 2025. Trend: 2023 $1,552 · 2024 $1,119 · 2025 $1,426
Food & beverage: $1,426
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $273 |
| Lilly USA, LLC | 14 | $222 |
| Corcept Therapeutics | 7 | $202 |
| Amgen Inc. | 8 | $144 |
| PFIZER INC. | 6 | $134 |
| AstraZeneca Pharmaceuticals LP | 6 | $102 |
| ABBVIE INC. | 5 | $82 |
| Lundbeck LLC | 2 | $60 |
| Esperion Therapeutics, Inc. | 2 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
Products named: Korlym, Rybelsus, MOUNJARO, NURTEC ODT, FARXIGA, Ozempic, UBRELVY, EVENITY.
Industry payments across MS — which companies pay providers there.
